Search for Clinical Trial Results

Sponsored By

Ependymoma - 48 Studies Found

Status Study
Recruiting Study Name: Carboplatin and Bevacizumab for Recurrent Ependymoma
Condition:
  • Ependymoma
  • Anaplastic Ependymoma

Date: 2011-02-11
Interventions:
  • Drug: Carboplatin Carboplatin

Recruiting Study Name: Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
Condition:
  • Glioblastoma Multiforme
  • Astrocytoma, Grade III
  • Date: 2016-03-17
    Interventions:
    • Biological: Heat Shock Protein Peptide Complex-96 (HSPPC-96)

Withdrawn Study Name: Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors
Condition:
  • Malignant Intracranial Tumors
  • Glioblastoma Multiforme
  • Anap
    Date: 2005-10-20
    Interventions: Procedure: Photodynamic therapy using Photosan and LumaCare™ Lamp Model LC-122M
Active, not recruiting Study Name: Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
Condition:
  • Adult Anaplastic Astrocytoma
  • Adult Anaplastic Ependymoma
    • <
    Date: 2011-11-17
    Interventions:
    • Drug: Temozolomide Given PO
Completed Study Name: Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2
Condition:
  • Anaplastic Astrocytoma
  • Anaplastic Ependymoma
  • Biological: therapeutic allogeneic lymphocytes

Recruiting Study Name: Everolimus for Children With Recurrent or Progressive Ependymoma
Condition: Recurrent Childhood Ependymoma
Date: 2014-05-29
Interventions: Drug: Everolimus The recommended dose of Everolimus is 4.5 mg/m2/dose, once daily for up to 2 years, unt
Terminated Study Name: Antineoplaston Therapy in Treating Patients With Ependymoma
Condition: Ependymoma
Date: 1999-11-01
Interventions: Drug: Antineoplaston therapy (Atengenal + Astugenal) Patients with an ependymoma will receive Antineopla
Terminated Study Name: Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
Condition:
  • Brain Tumor
  • Anaplastic Astrocytoma
  • A
    Date: 2010-03-26
    Interventions:
    • Drug: ritonavir Given orally
Not yet recruiting Study Name: Phase II Pediatric Study With Dabrafenib in HGG Patients
Condition:
  • Anaplastic Astrocytoma
  • Glioblastoma
  • Giant Cell Glioblastom
    Date: 2016-02-04
    Interventions: Drug: dabrafenib dabrafenib oral, twice daily. Patient dose based on weight and age. Patients will recei
Not yet recruiting Study Name: Phase I/II Trial of Safety and Anti-tumor Efficacy of AXL1717(Picropodophyllin) in the Treatment of Recurrent Malignant Astrocytomas
Condition:
  • Glioblastoma
  • Gliosarcoma
  • Anaplastic Astrocytoma
  • Date: 2012-10-29
    Interventions: Drug: AXL1717 IGF-1 receptor inhibitor Other Name: p
Next >>>